A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Primary Advanced or Recurrent Endometrial Cancer
Clinical trial NCT07652515 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07652515
- Sponsor
- GlaxoSmithKline
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-17
- Primary completion
- 2030-08-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.